AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
1.140
+0.010 (0.88%)
After-hours: Feb 21, 2025, 5:32 PM EST
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $33.76 million as of February 21, 2025. Its market cap has decreased by -94.33% in one year.
Market Cap
33.76M
Enterprise Value
-59.66M
1-Year Change
-94.33%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $33.76M, a decrease of -87.99%. That is a compound annual growth rate of -51.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 33.76M | -18.12% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |